NGI+ – The Next-Generation Precision of APSD Testing
Revolutionize APSD Testing with the Next-Generation Impactor NGI+.
Unmatched Durability and Precise Data for Inhaler Testing.
For experts conducting Aerodynamic Particle Size Distribution (APSD) measurements, the NGI+ takes inhalation drug testing to the next level. Built upon the trusted Next Generation Impactor (NGI) design, the NGI+ features enhanced corrosion resistance, improved chemical compatibility, and extended equipment life - ensuring more reliable, repeatable APSD results across a wider range of formulations.
Why Choose NGI+ for APSD Testing?
- Precise APSD Characterization – Achieve accurate and reliable measurements with industry-leading impactor performance, supporting a wider range of drugs and delivery systems.
- Enhanced Durability – Featuring superior corrosion resistance and chemical compatibility, the NGI+ is ideal for testing nebulizers, dry powder, and high-saline formulations, ensuring long-term reliability.
- Robust Cleaning Options – Designed for automated cleaning and harsh cleaning agents, the NGI+ minimizes cross-contamination risks and reduces cleaning time.
- Seamless Integration – Easily upgrade your existing NGI system without workflow disruption, extending the lifespan of your equipment.
Real-World Applications of NGI+
- Nebulizer & Biologic Testing – Ideal for high-saline and protein-based formulations, providing reliable APSD data.
- Improved Method Robustness – The NGI+ reduces material degradation, offering consistent, high-quality APSD measurements over time.
- Faster, Safer Cleaning – Supports automated cleaning and chemical-based cleaning methods, reducing downtime and improving productivity.